Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.22 USD | -1.28% | +6.90% | +0.42% |
Mar. 20 | Myriad Genetics Gets US Patent for SneakPeek Snap Device | MT |
Feb. 27 | Transcript : Myriad Genetics, Inc., Q4 2023 Earnings Call, Feb 27, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.42% | 1.76B | |
-9.59% | 7.67B | |
-1.20% | 5.41B | |
+26.10% | 4.62B | |
+0.02% | 4.57B | |
-53.02% | 3.22B | |
+6.42% | 2.59B | |
-14.95% | 2.05B | |
-8.29% | 1.79B | |
+4.65% | 1.62B |
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Goldman Sachs Upgrades Myriad Genetics to Buy From Sell, Raises Price Target to $25 From $18